Cardiomyopathy secondary prevention
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Lina Ya’qoub, MD; Edzel Lorraine Co, DMD, MD[2]
ICD placement is also recommended for secondary prevention in patients who survived sustained ventricular tachycardia or ventricular fibrillation.
References
Template:WH Template:WS Template:CALISKAN, K. , SZILI‐TOROK, T. , THEUNS, D. A., KARDOS, A. , GELEIJNSE, M. L., BALK, A. H., VAN DOMBURG, R. T., JORDAENS, L. and SIMOONS, M. L. (2011), Indications and Outcome of Implantable Cardioverter‐Defibrillators for Primary and Secondary Prophy
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
